Skip to main content
. 2017 Dec 5;24(12):e00268-17. doi: 10.1128/CVI.00268-17

TABLE 2.

Potential target populations for eventual deployment of a licensed CMV vaccine

Objective and target population for CMV vaccination
Universal vaccination of 12-year-old boys and girls
Vaccination of seronegative women of child-bearing age
Vaccination of seropositive women of child-bearing age (prevention of recurrent infection)
Universal immunization of all infants
Vaccination of SOT and HSCT recipients
Vaccination of HSCT donors